Company Search:
Advanced Search
Sponsored Links
BioRestorative Therapies Inc Company Snapshot
BioRestorative Therapies Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares BioRestorative Therapies Inc with three other companies in this sector in the United States: Vitality Biopharma Inc (2018 sales of $102,419.00 ), Exicure Inc ($118,000.00 ), and Matinas BioPharma Holdings Inc ($119,750.00 of which 100% was clinical-stage biopharmaceutical).

Sales Analysis. BioRestorative Therapies Inc reported sales of $111,000.00 for the year ending December of 2018. This represents an increase of 37.0% versus 2017, when the company's sales were $81,000.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BioRestorative Therapies Inc
  Stock Performance Chart for BioRestorative Therapies Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): .13
(Figures in U.S. Dollars)
1 Week -30.5%   13 Weeks -60.6%  
4 Weeks -63.6%   52 Weeks -90.8%  
BioRestorative Therapies Inc Key Data:
  Ticker: BRTX Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 111,000
(Year Ending Jan 2019).
Employees: N/A
  Currency: U.S. Dollars Market Cap: 2,573,152
  Fiscal Yr Ends: December Shares Outstanding: 19,793,477
  Share Type: Common Closely Held Shares: 5,911,676
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.